Cancer has long been medicine’s most elusive target, but a wave of new research suggests scientists may finally be closing in on a single vaccine platform that can tackle many different tumors.

Editorial: Over the holiday period, the Guardian leader column is looking ahead at the themes of 2026. Today we examine how the White House’s war on vaccines has left the future of a key technology un ...

Stanford researchers identified a two-step immune process causing rare myocarditis after mRNA COVID-19 vaccines, primarily in ...

WASHINGTON, DC: Jayanta Bhattacharya, Director of the National Institutes of Health. (Photo by Andrew Harnik/Getty Images) Director of the National Institutes of Health, Jay Bhattacharya, recently ...

The study examined 180 patients with advanced lung cancer who received a COVID vaccine within 100 days before or after beginning immunotherapy, as well as 704 similar patients who did not. Vaccinated ...

Research on mRNA vaccines have been under fire in the post-pandemic age, but these immunotherapies are showing promise in the ...

Stanford scientists have uncovered how mRNA COVID-19 vaccines can very rarely trigger heart inflammation in young men — and ...

Hello and welcome to Health Affairs This Week. I'm your host, Jeff Beyers. We're recording on 08/21/2025. Health Affairs has a lot of virtual events coming up in the next couple of weeks. So just ...

On Sept. 4, 2025, Health and Human Services Secretary Robert F. Kennedy Jr. is scheduled to testify before the Senate Finance Committee, where he is expected to face questions about his vaccine ...

At a Sept. 4, 2025, hearing before the Senate Finance Committee, Health and Human Services Secretary Robert F. Kennedy Jr. faced heated questions from numerous senators about his vaccine policies, ...